Abattis Signs MOU with Global Damon Pharma of South Korea (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / October 5, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce that it has entered into a Memorandum of Understanding with Global Damon Pharma (“GDP”) of South Korea, to distribute and sell Abattis’ proprietary PhytoNOS™ and Sassy™ Tonics in modified formulations. GDP will engage in […]

Update: New Science Advisor and Comptroller Appointment to Abattis (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / September 27, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce the appointment of Dr. Shuang Xie as its newest Science and Technology Advisor. Dr. Xie graduated from Zhejiang University in 1987 and Queen’s University in 1993. Dr. Xie has been widely published and holds […]